Validation of the Dayzz Digital Sleep Training App in Insomnia and Sleep Apnea
1 other identifier
interventional
125
1 country
1
Brief Summary
The prevalence of sleep disorders has achieved epidemic proportions in Western countries. Despite this, assessment and treatment of sleep disorders remains infrequent, unattainable, and often costly. Dayzz is aware of the need for easily accessible, user-friendly, and affordable treatment strategies for known sleep conditions. This research proposes a randomized controlled outcome study aimed to validate a, digitized, cost-effective mobile app which assesses and manages insomnia and CPAP adherence in persons with sleep apnea. The app's sleep training protocols recommend life-style and behavioral changes and tracks these changes with the aim of improving sleep and well-being. In this study, the dayzz app digital treatment protocol will be compared to the standard treatment for these sleep conditions by a sleep professional.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2019
CompletedFirst Submitted
Initial submission to the registry
February 7, 2019
CompletedFirst Posted
Study publicly available on registry
May 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedAugust 19, 2021
August 1, 2021
1.9 years
February 7, 2019
August 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Total sleep time (minutes)
sleep duration in minutes per night (based on nightly sleep diary)
3 months to 1 year
Sleep onset latency (minutes)
Number of minutes to fall asleep per night (based on nightly sleep diary)
3 months to 1 year
Wake after sleep onset (minutes)
Number of minutes awake in total per night (based on nightly sleep diary)
3 months to 1 year
Sleep efficiency (percent)
(Number of minutes asleep per night/number of minutes in bed per night)\*100 (based on sleep diary data)
3 months to 1 year
Sleep quality
Likert scale of sleep quality between 1 and 10 (based on sleep diary report)
3 months to 1 year
Nightly CPAP use
Minutes of wearing the CPAP mask per night (based on sleep diary report)
3 months to 1 year
Excessive daytime sleepiness
The Epworth Sleepiness Scale (ESS): The ESS is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3), their usual chances of dozing off or falling asleep while engaged in eight different activities. The ESS score (the sum of 8 item scores, 0-3) can range from 0 to 24. The higher the ESS score, the higher that person's average sleep propensity or their 'daytime sleepiness'.
3 months to 1 year
Sleep symptom screening questionnaire
The Dayzz Sleep Questionnaire is a digitized screening measure that assesses sleep quantity and quality and presence/risk for specific sleep disorders. It is composed of some self-rated items, assessing sleep amounts, sleep quality, excessive sleepiness, and risk factors for sleep-related breathing disorders, symptoms of insomnia and sleep/wake circadian rhythms. The questions are based on the International Classification of Sleep Disorders (3rd Edition; American Academy of Sleep Medicine) diagnostic criteria for four common categories of sleep disorders: Insomnia, Insufficient Sleep Syndrome, Sleep Apnea Disorders, and Circadian Rhythm Sleep-Wake Disorders.
3 months to 1 year
Insomnia severity
The Insomnia Severity Index (ISI) is a well-validated 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia over the past month (Morin, 1993). The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).
3 months to 1 year
Secondary Outcomes (4)
Work productivity
3 months to 1 year
Insomnia-related quality of life
3 months to 1 year
Sleep Apnea-related Quality of Life-Short form (SAQLI-SF)
3 months to 1 year
The WHO-5 Well-being Index (WHO-5)
3 months to 1 year
Study Arms (4)
Sleep Apnea- Dayzz
EXPERIMENTALThe intervention group is also provided access to the dayzz app, a personalized digital sleep training program. The sleep training begins a sleep assessment questionnaire and ongoing sleep and activity data collection which is used to tailor an individualized sleep training program including behavioral and cognitive techniques to improve the adherence to CPAP. The dayzz sleep program is composed of three main components, (1) a mobile digital program via the dayzz app, (2) guidance of a sleep trainer, and (3) an ambulatory sleep monitoring device. The intervention group meets a CPAP technician at the sleep clinic, as detailed below in the Sleep Apnea TAU group
Sleep Apnea- Treatment as Usual
ACTIVE COMPARATORThe "treatment as usual" \[TAU\] group meets a CPAP technician at the sleep clinic, who provides the participant with a CPAP device and fits the mask. The will also receive a follow-up visit with the same technician for technical support, mask changes or alterations if needed after an initial 7 to 14-day at home CPAP trial.
Insomnia - Dayzz
EXPERIMENTALThe intervention group is provided access to the dayzz app, a personalized digital sleep training program. The sleep training begins a sleep assessment questionnaire and ongoing sleep and activity data collection which is used to tailor an individualized sleep training program including behavioral and cognitive techniques to improve the insomnia concerns, sleep symptoms, and achieve sleep goals. The dayzz sleep program is composed of three main components, (1) a mobile digital program via the dayzz app, (2) guidance of a sleep trainer, and (3) an ambulatory sleep monitoring device.
Insomnia - Treatment as Usual
ACTIVE COMPARATORThe "treatment as usual" \[TAU\] group, will receive standard treatment recommendations for their insomnia, including sleep hygiene suggestions, referral for supportive/non-medical treatments \[e.g. relaxation therapies\], and if needed hypnotics or other medications prescribed by the sleep clinic physician.
Interventions
1. The dayzz digital sleep program provides each user with relevant educational materials (depending on their sleep condition), sleep tracking, and sleep or health-related tasks or challenges pertaining to their sleep or sleep difficulties. 2. Each app user is matched with a "sleep trainer" who will communicate with them via a "chat" option within the dayzz app and who will support the participants with any sleep training issues or technical aspects of all app for the duration of the treatment program. 3. Participants receive a wrist-worn device for monitoring sleep and activity patterns, a Fitbit fitness tracker (www.fitbit.com), to be worn for the duration of the study.
Standard medical care for specific sleep condition
Eligibility Criteria
You may qualify if:
- Patients aged 21-65 years of age referred to the Carmel Hospital sleep clinic and diagnosed by the clinic physician with either Sleep Apnea (referred for CPAP treatment) or Insomnia.
You may not qualify if:
- Patient age \<21 years.
- Patient who is not a member of Clalit Healthcare services.
- Persons with insufficient control of the English language required for adequate use of app.
- Persons with insufficient experience/knowledge and/or use of digital apps/smartphones.
- Persons with serious medical or psychiatric conditions.
- Women who are pregnant or breastfeeding.
- Nighttime shift-workers.
- Persons who are unable to provide consent due to mental incapacity.
- Persons referred for evaluation of sleep by Ministry of Transportation (for licensing purposes).
- Persons with comorbid insomnia and sleep apnea
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dayzz Live Well Ltd.lead
- Israel Innovation Authoritycollaborator
Study Sites (1)
Carmel Hospital
Haifa, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2019
First Posted
May 17, 2019
Study Start
January 29, 2019
Primary Completion
December 30, 2020
Study Completion
December 30, 2020
Last Updated
August 19, 2021
Record last verified: 2021-08